Specific desensitization of actin polymerization of bovine platelets

Specific desensitization of actin polymerization of bovine platelets

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS Pages 846-850 Vol. 120, No. 3, 1984 May 16, 1984 SPECIFIC DESENSITIZATION OF ACTIN POLYMERIZATIO...

277KB Sizes 2 Downloads 73 Views

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS Pages 846-850

Vol. 120, No. 3, 1984 May 16, 1984

SPECIFIC DESENSITIZATION OF ACTIN POLYMERIZATION OF BOVINE PLATELETS T. Imada, T. Kikuchi, H. Shimada, Y. Inada, and Y. Saito Laboratory of Biological Chemistry, Tokyo Institute of Technology Ookayama, Meguroku, Tokyo 152, Japan Received April 2, 1984 SUMMARY: Polymerization of actin induced by activation of platelets was investigated using deoxyribonuclease I inhibition assay. When platelets were activated with ADP or 5-hydroxytryptamine, actin was polymerized quickly followed by rapid depolymerization to the initial level. Reactivation with the same agonist, however, did not cause the polymerization of actin, though with different agonists actin polymerized quite normally. The mechanism for this agonist-specific desensitization of actin polymerization was investigated by the use of a calcium ionophore A23187. It was suggested that the cause for the desensitization is the inability of platelets to mobilize Ca 2+ in response to specific agonist.

Previously we platelets.

have

They

studied

agonist-specific

desensitization

of

bovine

lost its ability to aggregate in response to an agonist when

they were preincubated with the agonist, namely they were desensitized. However, those desensitized platelets aggregated quite normally by We

also

other

agonists(1).

observed a similar phenomenon on the platelet shape change by light

scattering technique and scanning electron microscopy(unpublished data). Platelet actin is one of platelets

are

the main

activated with

components

of

cytoskeleton,

and when

agonists it begins to polymerize prior to shape

change and aggregation(2,3). In

this

communication,

polymerization

in

order

interaction with agonists. different

types

we

have

studied

to

elucidate

the desensitization

responses

Desensitization

of

platelets

to agonists

is

of after

actin the

observed with

of cells, and it might be one of the basic cellular regulatory

mechanisms(4).

ABBREVIATIONS: DNase I; deoxyribonuclease I, 5HT; 5-hydroxytryptamine ACD; acid-citrate dextrose, PRP; platelet rich p--~sma 0006-291X/84 $1.50 Copyr~ht © 1984byAcademic Press, Inc. Allrightsofreproductionin anyform reserved.

846

Vol. 120, No. 3, 1984

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

MATERIALS AND METHODS ADP(disodium salt) and 5-hydroxytryptamine(creatinine sulfate) were obtained from Yamasa Shoyu Co.(Chiba, Japan) and from Tokyo Kasei Co.(Tokyo, Japan), respectively. A calcium ionophore A23187 and DNA from calf thymus(Type I) and deoxyribonuclease I(DNase I) from bovine panereas(DN-100) were purchased from Sigma Chemical Co.(St. Louis, Mo.). All other chemicals were of analytical grade. Preparation of platelet rich plasma and washed platelet suspension: Bovine blood was obtained at a local slaughter house and anticoagulated with acid-citrate dextrose(ACD). Platelet rich plasma(PRP) and washed platelet suspension in Tris-ACD buffer were prepared by successive ¢entrifugation at different speeds according to a procedure described previously(5). Platelet activation: Fifty ~i of Tris-ACD containing ADP or 5-hydroxytryptamineC5HT) were added to 450 ~i of PRP under stirring at 37°C. A23187 was dissolved in dimethylsulfoxide, and 5 ~i of the solution were added to 500 ~i of washed platelet suspension under stirring at 37°C. Measurement of polymerization of actin by DNase I inhibition assay: Specific inhibition of the activity of DNase I by monomerie actin was measured as follows. One hundred ~i of platelet samples were mixed with i00 ~i of Triton lysis buffer[2% Triton X-100, i0 mM EGTA and i00 mM Tris-HCl(pH 7.4)] and were then diluted with the same volume of Tris-ACD. Fifty ~i of the resultant lysates were mixed with 200 ~i of DNase I solution[15-30 ~g/ml in 50 mM Tris-HCl(pH 7.5) with 0.i mM CaCI2]. Two hundred ~i of the mixtures were added to 3 ml of DNA solution[50 ~g/ml in 4 mM MgSOa, 1.8 mM CaCI 2 and Tris-HCl(pH 7.5)] and the increase of the absorbance at 260 nm in the initial 2 min was recorded with a Shimadzu UV-200 spectrophotometer. All the steps above were handled within 30 seconds. The inhibition of DNase I activity by total actin was determined after depolymerizing all actin molecules with 0.75 M guanidine-HCl at 0°C for 20 to 30 min(6). The final concentration of guanidine-HCl was 9.4 mM, and it did not affect the measurement by itself. The percentage of monomerie actin against total actin was then calculated from those values of inhibition using a standard curve according to a procedure described by Fox et al.(6). RESULTS AND DISCUSSION Platelet actin is known to polymerize after activation of platelets with some kinds of agonists including thrombin(3). this

phenomenon by

Using bovine platelets

activating them with ADP and 5HT.

we

confirmed

As it is shown in Fig.

i(-o-), when platelets were activated with ADP, monomeric actin rapidly began to polymerize and reached to the maximum within 1 min, and quickly depolymerized to the basal level. about by

This quick change of the state

the activation of

platelets

with

of

actin was

5HT(data

also

not shown).

brought We next

examined whether the actin polymerization was affected by the preactivation with same or a different agonist. later

The second addition of ADP to platelets,

i0 min

after they had been exposed to ADP, did not cause polymerization of actin

at all(shown by -e-).

In contrast, when 5HT was used as the second activator,

the quick change

the state of actin was observed(shown by -A-), as if the

of

preactivation with ADP did not affect the second activation with 847

5HT at

all.

Vol. 120, No. 3, 1984

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

"o

,

,

a

b



4o

"v"

E

g ao ~6 0

' IO

o

Incubation

~o

-time

( rain )

A~onist-specific desensitization of actin polymerization. Platelets 09/ml~ in PRP were activated with i0 ~M ADP(-o-)at time zero indicated by the arrow a. They were then activated i0 min later indicated by the arrow b either with i0 ~M ADP(-o-) or i00 ~M 5HT(-A-). At different times a portion of PRP was withdrawn and the amount of monomeric actin decreased from that at time zero, which is the % actin polymerized shown on the ordinate, was determined by the DNase I inhibition assay described in Methods.

This

agonist-specific

desensitization

of

actin

polymerization

was

observed when platelets were preactivated with 5HT; the second addition I0 min later

of

also 5HT

did not cause the polymerization of actin, whereas that of ADP did

cause the polymerization quite normally(data not shown). Polymerization of actin is apparently a very different

phenomenon,

are known to change their activities

concentration of Ca2+(8).

It is quite possible some

complex

mechanisms.

directly

receptors(10).

As

The

initiates the actin polymerization

the

interaction

0.i ~M.

of

of

agonists

with

specific

we expected, the addition of A23187 to platelet suspension

time

in

dose-dependent

manner,

as

it

is

shown

in

course for the change of the state of actin induced by

A23187 was similar to those observed with ADP and percentage

Ca2+(9).

We used a calcium ionophore A23187 in order to

without

induced actin polymerization Fig.2(-o-).

on

When platelets are activated with agonists, one

that this mobilization

mobilize Ca 2+

many

Some of

depending

of the very early events observed is the mobilization of intracellular

by

and

kinds of proteins are involved to regulate the reaction(7).

those actin-bindingproteins the

complex

5HT(data

not

shown).

The

actin polymerized reached to its maximum level of 30 to 35% with

Since platelet preparation used in this figure was different from that

used in Fig.l, values of % actin polymerized between these two figures necessarily

comparable.

There

are

two 848

are

not

major observations we would like to

Vol. 120, No. 3, 1984

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS t¢

4C

oc

y

"O

A I I r



ae

o,

o'.z

~ z'z

Concentration of A25187

( pM )

PolymeKization of actin in platelets activated with A23187 and ADP. ets(2 x lO~/ml) in Tris-ACD were activated with varied concentrations of a calcium ionophore A23187. Platelets were lysed 30 seconds later after the activation and the % actin polymerized by the activation(-o-) was determined by the DNase I inhibition assay described in Methods. The maximum extent of the % actin polymerized by the activation with ADP(20 ~M) was shown by A, and that obtained with ADP(20 ~M) plus A23187(0.24 ~M) was shown by A.

emphasize in this experiment.

First, the maximum extent of actin

polymerized

by the addition of A23187 was always bigger than that obtained by ADP(shownby A in

this

figure)

Second,

or

5HT(data

not

shown), or that obtained bybothcombined.

the maximum extent of actin polymerized with A23187

did not become any

bigger by the simultaneous addition of high concentration of ADP(shown by this

figure).

These

would

imply

that

the

initial

signal

Ca 2+

in

for the aetin

polymerization is the mobilization of intracelhlar Ca 2+, and that each mobilizes

A

agonist

from specific pools and A23187 could mobilize from all of these

pools. Taking advantage of the above conclusion, we thought about the following mechanisms

for the desensitization of aetin polymerization.

itself can not respond to the mobilized Ca 2+. A23187

to

ADP-desensitized

the

mobilization

mobilized. should

the

addition

of

Ca 2+,

The other is that the

agonist

normal

actin polymerization.

As we have already shown, the

of

the preactivation of

polymerization

of

can

not

but actin itself can polymerize if Ca 2+ is

In this case, the addition of A23187 to ADP-desensitized

cause

diminished

One is that actin

platelets should cause decreased polymerization of

actin than that in control platelets. induce

In this case,

two

platelets

Results are presented in Table i. platelets with

ADP

completely

actin induced by the second activation with 849

Vol. 120, No. 3, 1984

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Table l: The effect of ADP-induced desensitization on the actin polymerization observed by the activation with A23187. At time zero, 0.24 ~M A23187 or 20 ~M ADP was added to washed platelets(2 x 109/ml) to activate them, and i0 min later A23187 or ADP was again added at the same concentrations. Thirty seconds later after each activation platelets were lysed and the % aetin polymerized by the activation was determined by the DNase I inhibition assay described in Methods. First Activation Agonist % Actin Polymerized A23187 35 ADP 22 ADP 22

ADP.

Second Activation Agonist % Actin Polymerized ADP A23187

In contrast, A23187 caused 35% of aetin

0 35

polymerized

regardless

of

the

preactivation with ADP. The

real

cause

for

the

polymerization should then be that intracellular

Ca 2+

in

response

agonist-specific platelets

This would also make

previously

agonist-specifie

change.

incapable

of

of

aetin

mobilizing

to an agonist after they are exposed to that

particular agonist. observed

become

desensitization

a

reasonable

explanation

for

the

desensitization of aggregation and shape

We are currently investigating whether

a

specific

receptor

becomes

inaccessible to an agonist. REFERENCES i.

Imada, T., Saito, Y., Shimada, H. and Inada, Y., (1983) Thrombos. Res., 31, 807-815. 2. Jennings, L. K., Fox, J. E. B., Edwards, H. H. and Phillips, D. R., (1981) J. Biol. Chem., 256, 6927-6932. 3. Pribluda, V., Laub, F. and Rotman, A., (1981) Eur. J. Bioehem., 116, 293-296. 4.~ Raff, M., (1976) Nature, 259, 265-266. 5. Saito, Y., Imada, T. and Inada, Y., (1980) Thrombos. Res., 17, 809-818. 6. Fox, J. E. B., Doekter, M. E. and Phillips, D. R., (1981) Anal. Bioehem., 117, 170-177. 7. Weeds, A., (1982) Nature, 296, 811-816. 8. Wang~ L. and Bryan, J., (1981) Cell, 25, 637-649. 9. Massini, P., K~ser-Granzmann, R. and Iflscher, E. F., (1978) Thrombos. Haemostas., 40, 212-218. i0. Mensehe, D., Israel, A. and Karpatkin, S., (1980) J. Clin. Invest., 66, 284-291.

850